Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Jasper Alabama

Patients are needed to participate in a clinical research study of nintedanib and placebo to evaluate Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Arizona

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Tucson Arizona 85723

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Tucson Arizona 85724

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

California

University of California, San Francisco
San Francisco California 94143

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

UPDATED

San Francisco California 94143

A Phase 2 clinical study for patients with Idiopathic Pulmonary Fibrosis (IPF)

La Jolla California 92037

A clinical research study of Pirfenidone and Vismodegib for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90024

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90073

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease or Pulmonary Hypertension

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating treprostinil for the treatment of Pulmonary Arterial Hypertension, Interstitial Lung Disease or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90024

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Sacramento California 95817

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Sacramento California 95817

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Stanford California 94305

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Colorado

Denver Colorado 80206

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Wheat Ridge Colorado 80033

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Connecticut

UPDATED

New Haven Connecticut 06520

A Phase 2 clinical study for patients with Idiopathic Pulmonary Fibrosis (IPF)

UPDATED

Stamford Connecticut

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Danbury Connecticut

A Phase 4 clinical study for patients with Idiopathic Pulmonary Fibrosis

New Haven Connecticut 06520

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

New Haven Connecticut 06520

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

View More ▼

New Haven Connecticut 06520

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Florida

Pulmonary Disease Specialists, PA, d/b/a PDS Research
Kissimmee Florida

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

University of Miami Pulmonary Clinics
Miami Florida 33136

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Clearwater Florida 33756

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Jacksonville Florida 32224

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Kissimmee Florida 34741

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Kissimmee Florida 34741

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Orlando Florida 32803

A clinical research study of Pirfenidone and Vismodegib for the treatment of Idiopathic Pulmonary Fibrosis

Orlando Florida 32803

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Pensacola Florida 32504

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Georgia

Emory University
Atlanta Georgia 30322

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Illinois

Chicago Illinois 60637

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Indiana

Muncie Indiana 47303

A clinical research study of Pirfenidone and Vismodegib for the treatment of Idiopathic Pulmonary Fibrosis

Kansas

University of Kansas
Kansas City Kansas

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Via Christi Research
Wichita Kansas 67214

FG-3019 for Idiopathic Pulmonary Fibrosis

Via Christi Research
Wichita Kansas 67214

Lebrikizumab for Idiopathic Pulmonary Fibrosis

Via Christi Research
Wichita Kansas 67214

LPA Antagonist for Idiopathic Pulmonary Fibrosis